Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Xavier Calvo

Showing results (51-60 of 58) with videos related to

Pageof 6
Sort By:
You have reached the last page of results.This site can display upto 58 results.
Cancers|August 12, 2022
<i>TP53</i> Abnormalities Are Underlying the Poor Outcome Associated with Chromothripsis in Chronic Lymphocytic Leukemia Patients with Complex KaryotypeSilvia Ramos-Campoy, Anna Puiggros, Joanna Kamaso, et al.
Leukemia Research|November 10, 2017
Clinical and biological significance of isolated Y chromosome loss in myelodysplastic syndromes and chronic myelomonocytic leukemia. A report from the Spanish MDS GroupMeritxell Nomdedeu, Arturo Pereira, Xavier Calvo, et al.
Genes, Chromosomes & Cancer|May 21, 2013
Reciprocal translocations in myelodysplastic syndromes and chronic myelomonocytic leukemias: review of 5,654 patients with an evaluable karyotypeDolors Costa, Concha Muñoz, Ana Carrió, et al.
Genes, Chromosomes & Cancer|December 23, 2015
Prognostic impact of chromosomal translocations in myelodysplastic syndromes and chronic myelomonocytic leukemia patients. A study by the spanish group of myelodysplastic syndromesMeritxell Nomdedeu, Xavier Calvo, Arturo Pereira, et al.
Haematologica|June 30, 2018
Pharmacological modulation of CXCR4 cooperates with BET bromodomain inhibition in diffuse large B-cell lymphomaClara Recasens-Zorzo, Teresa Cardesa-Salzmann, Paolo Petazzi, et al.
Blood Advances|October 10, 2024
AML typical mutations (CEBPA, FLT3, NPM1) identify a high-risk chronic myelomonocytic leukemia independent of CPSS molecularSandra Castaño-Díez, Mònica López-Guerra, Inés Zugasti, et al.
Blood Cancer Discovery|January 26, 2026
Incorporation of genomic determinants improves diagnostic accuracy of oligomonocytic chronic myelomonocytic leukemiaGuillermo Montalban-Bravo, Chong Wu, Juan Jose Rodriguez-Sevilla, et al.
Blood Cancer Journal|September 4, 2023
Baseline immunophenotypic profile of bone marrow leukemia cells in acute myeloid leukemia with nucleophosmin-1 gene mutation: a EuroFlow studySergio Matarraz, Pilar Leoz, Ana Yeguas-Bermejo, et al.
Pageof 6

Showing results (51-60 of 58) with videos related to

Sort By:
Pageof 6
You have reached the last page of results.This site can display upto 58 results.
Cancers|August 12, 2022
<i>TP53</i> Abnormalities Are Underlying the Poor Outcome Associated with Chromothripsis in Chronic Lymphocytic Leukemia Patients with Complex KaryotypeSilvia Ramos-Campoy, Anna Puiggros, Joanna Kamaso, et al.
Leukemia Research|November 10, 2017
Clinical and biological significance of isolated Y chromosome loss in myelodysplastic syndromes and chronic myelomonocytic leukemia. A report from the Spanish MDS GroupMeritxell Nomdedeu, Arturo Pereira, Xavier Calvo, et al.
Genes, Chromosomes & Cancer|May 21, 2013
Reciprocal translocations in myelodysplastic syndromes and chronic myelomonocytic leukemias: review of 5,654 patients with an evaluable karyotypeDolors Costa, Concha Muñoz, Ana Carrió, et al.
Genes, Chromosomes & Cancer|December 23, 2015
Prognostic impact of chromosomal translocations in myelodysplastic syndromes and chronic myelomonocytic leukemia patients. A study by the spanish group of myelodysplastic syndromesMeritxell Nomdedeu, Xavier Calvo, Arturo Pereira, et al.
Haematologica|June 30, 2018
Pharmacological modulation of CXCR4 cooperates with BET bromodomain inhibition in diffuse large B-cell lymphomaClara Recasens-Zorzo, Teresa Cardesa-Salzmann, Paolo Petazzi, et al.
Blood Advances|October 10, 2024
AML typical mutations (CEBPA, FLT3, NPM1) identify a high-risk chronic myelomonocytic leukemia independent of CPSS molecularSandra Castaño-Díez, Mònica López-Guerra, Inés Zugasti, et al.
Blood Cancer Discovery|January 26, 2026
Incorporation of genomic determinants improves diagnostic accuracy of oligomonocytic chronic myelomonocytic leukemiaGuillermo Montalban-Bravo, Chong Wu, Juan Jose Rodriguez-Sevilla, et al.
Blood Cancer Journal|September 4, 2023
Baseline immunophenotypic profile of bone marrow leukemia cells in acute myeloid leukemia with nucleophosmin-1 gene mutation: a EuroFlow studySergio Matarraz, Pilar Leoz, Ana Yeguas-Bermejo, et al.
Pageof 6